Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
The cause of mental disorders such as depression remains unknown. However, the idea that neurotransmitter imbalances cause depression is vigorously promoted by pharmaceutical companies and the psychiatric profession at large. We examine...
Dr. Frosch and colleagues' research provides important counterevidence to the pharmaceutical industry's claim that consumer advertising has educational value [1]. We would like to suggest an additional point which will strengthen their...
Knowledge of Undisclosed Corporate Authorship ("Ghostwriting") Reduces the Perceived Credibility of Antidepressant Research: A Randomized Vignette Study with Experienced Nurses
Background: There is much concern regarding undisclosed corporate authorship ("ghostwriting") in the peer-reviewed medical literature. However, there are no studies of how disclosure of ghostwriting alone impacts the perceived...
Background: While the impact of conflicts-of-interest (COI) is of increasing concern in academic medicine, there is little research on the reaction of practicing clinicians to the disclosure of such conflicts. We developed two research...
We would like to clarify one statement in Dr. Frosch's reply (1), in which he states that the accuracy of advertisements awaits further investigation. Regarding Zoloft advertisements, as we pointed out in our letter, they have already...
Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
